Different molecular mechanisms may modulate sensitization and natural or induced tolerance to allergens. We have searched for differential mechanisms at humoral and cellular level in the olive pollen a~l ergi c response, checking the influence of exposure to allergens of subjects from an area with extremely high antigenic load during the pollen season. Sera and PBMCs were obtained during and outside the pollen season. Distinct Ig subtypes (total IgE and specific IgE, IgG4 and IgA), and Thl, Th2 and regulatory T cells (Treg) cytokines were analyzed in 5 groups of subjects: Group 1, non-allergic; Group 2, asymptomatic, sensitized to olive pollen; Group 3, allergic to pollen other than olive; Group 4, allergic to olive pollen (not treated); and Group 5, allergic to olive pollen, and getting specific immunotherapy. Asymptomatic subjects showed the highest total IgE levels. The major difference found between untreated and treated subjects was the high levels of non-inflammatory antibodies (lgG4) in treated patients. The main result of cytokine analyses was the statistically significant decrease in TGF-p levels in untreated olive pollen allergic subjects (pollen season) compared with treated. A slgnificnnt decrease In forkhead winged-helix transcription factor (FOXP3) mRNA expression (marker of regulatory response) and a lower presence of Treg cells in PBMCs of olive pollen allergic subjects was found. The results point to a decrease in the cellular regulatory mechanisms mediated by TGF-p and FOXP31n olive-pollen allergic patients that could be restored after specific-immunothernpy.
The reason why exposure to common cnvironmcntal antigens induces allergic diseases in Some people and not in others remains undetermined.
Allergen-specific CD4+ helper T-cell (Th) generation is the initial event leading to the development of allergic disease. Subtypes Th2 arc pivotal to the inflammatory cascade through production of IL-4 (essential for the development of Th2 cells), IL-S (for eosinophil recruitment), IL-13 (mediates isotype switching to IgE) and IL-9 (mucus hypersecretion). Th I cells (secreting mainly IFN-y) may contribute to the chronicity and effector phase of these diseases. Given that each of these subtypes regulates the other, immune deviation of Th2 to Th I has been extensively studied to determine the allergic regulation response.
Peripheral T-cel1 tolerance is characterized by functional inactivation of the cells in contact with the antigen, which in tum eliminates both the proliferative response and cytokine secretion. In humans, several T-cell subtypes with an immunosuppressive function, generically named regulatoryT cells (Treg) have been extensively studied (1). IL-IO and TGF-p, secreted by these Tregs, may play an important role the immunoregulatory response (2) (3) . Other cell subsets with suppressive capacity include COSt T cells, roT cells, CD4-CDS-T cells, IL-IO-producing B cells, IL-I O-producing NK cells, IL-l O-producing DC and some macrophage subsets (3) (4) . The main role of all these cell subsets is to maintain integrity of the body through avoiding excessive immune responses that may result in harmful immune pathology, as well as to keep a state of tolerance to innocuous substances (5) .
As is well known, differences between allergic and non-allergic responses can be observed by analyzing specific antibody levels in serum. Allergic patients show high levels of IgE antibodies whereas specific immunotherapy is associated with an increase in specific IgG4 levels, a deviation towards a Th I response, and an increase in IL-I 0 levels (6) .
Forkhcad winged-helix transcriptional factor (FOXP3) was identified as a specific molecular marker for Treg cells, and its expression is considered essential for Treg cell development and function (7) (8) (9) . Its absence is associated with severe allergic inflammation and high IgE levels (10) . FOXP3' Treg cells are generated in the thymus (nTreg) or induced in the periphery (iTreg) and the molecular mechanisms underlying their induction in human T cell have been extensively studied and recently reviewed (II). TGF-p plays a critical role in the induction of FOXP3 t Treg cells in vivo, in vitro and in Treg cell homeostasis, however its role as a suppressor molecule remains controversial (12) and its complex interaction with FOXP3 expression is still an unanswered question (13) .
In the present study, we used a special model of sensitization, olive pollen allergy, which is one of the major causes of respiratory allergy in the Mediterranean area and is present also in California. Olive pollen induces mainly nasal and conjunctival symptoms (14) , although it may also induce asthma exacerbations in areas with high antigenic load. Our patients were from Andalusia, a region in southern Spain with particularly high pollen counts during the pollen season (5,000 grains/m' with peaks reaching more than 10,000 grains/m-) and a high prevalence of asthma (15) . We previously described specific genetic and environmental factors associated with olive pollen allergy (16) (17) (18) (19) (20) . The interesting point of our study is that it was carried out in an area with unusually high antigenic load, where it had been previously demonstrated that patients had specific genetic restrictions and clinical symptoms depending on the nature of olive allergen implicated in sensitization . It was our aim to compare special characteristics of patients that respond to an elevated amount of antigen with those of healthy people under same allergenic conditions, living in the same area. In other words, we have analyzed response and non-response to olive pollen allergens, during and outside the pollen season, in order to find differential parameters that could prove useful in the diagnosis and/or prophylaxis of allergic diseases. Such studies are not often carried out, therefore it is worthwhile to develop them further.
MATERIALS AND METHODS

Subjects
Eighty-four unrelated subjects were recruited at the Allergy Service of four hospitals in Andalusia under two olive pollen exposure conditions: April to June, with very high pollen counts, and outside the pollen season, October to December, with low pollen counts. We establishcd 5 groups: Group I, seventeen non-allergic subjects (no history of respiratory allergies); Group 2, ten asymptomatic subjects, with olive pollen sensitization, positive skin test and no seasonal respiratory symptoms (rhinitis and/or asthma); Group 3, twenty patients who were allergic but not to olive pollen; Group 4, twentytwo untreated olive pollen allergic patients; and Group 5, fifteen olive pollen allergic patients treated with subcutaneous immunotherapy for Olea europaea pollen with standardized extracts (ALK-AbeIl6, Madrid, eRF-Leti, Barcelona, Bial-Aristegui, Bilbao, Spain). The highest-concentration of the major allergen (Ole e 1) corresponds to I0-15 ug. Treatment was continued at least for two years before being recruited into the study. t andard guidelines were used in the case of undercurrent Illness or adverse reactions (21) . . Olive pollen-allergic patients fulfilled the following Inclusion criteria: seasonal rhinitis and/or asthma from April to June, positive skin prick test for O. europaeã ol l en extract, and no previous' immunotherapy, except lor group 5. The exclusion criteria were: current smoking, ess than 10 years' residence in the selected area, and Corticosteroid or anti-histaminic treatment. Informed consent was obtained from each subject. Ethical approval Was obtained from the Ethical and Research Committee of each participating hospitals. -" pain), following the EAACI recommendations (2 I).
Isolation (~/' PBMCs .PBMCs were isolated from heparin-containing peripheral blood samples taken during and outside pollen season, by gradient centrifugation on Lymphoprep (Comercial Rufer, Zaragoza, Spain) following the l1lanufaeturer's instructions.
MeClsurement ofsoluble cytokine levels
Enzyme-linked immunoassay (ELISA) was applied to determine serum levels of IFN-y, IL-4, IL-5, IL-I3, lL-9, TNF-a, IL-IO (Diaclone, Besancon, France), IL-17 (e-Bioscience, San Diego, CA, USA), and TGF-~(Becton Dickinson, BD, San Diego, CA, USA).
QUClntitCllive real-time polymerase chain reaction analysis (peR)
Total RNA was extracted from PBMCs (10 6 cells) using the Trizol method (Invitrogen, Carlsbad, CA, USA). Reverse transcription was performed using High Capacity . RNA-to-cDNA Kit (Applied Biosysterns, Foster City, CA, USA). Real-time PCR was performed in triplicate using TaqMan Gene Expression and the ABI/Prism 7500 Sequence Detector System (Applied Biosystems). FOXP3 and 18S rRNA were analyzed with predesigned TaqMan Gene Expression assays (HsOI085834_ml and Hs9999990I_s I, respectively).
FOXP3 mRNA expression was normalized to that of 18S rRNA and calculated according to the comparative cycle threshold (C,) method, being the gene-expression represented as 2
corresponds to the non-allergic group values.
Confocal microscopy analysis in unfixed cells
CD4, CD25 and FOXP3 expression was analyzed in unfixed PBMCs by fluorescent confocal microscopy. Briefly, CD4 and CD25 were detected with PE-conjugated mouse-anti-Human CD4 and APC-conjugated mouseanti-Human CD25 monoclonal antibodies, respectively (BD Biosciences). Intracellular FOXP3 expression was detected with Alexa Fluor 488 mouse-anti-Human Foxp3 monoclonal antibody (BD Biosciences). Specific isotype controls were Alexa Fluor 488, PE and APC labeled mouse IgG I K isotype (BD Biosciences), Unfixed PBMCs (3x IO'cls)were analyzed in an 8-well microscopy chamber (Ibidi, Germany) using a confocal Microscope Leica SP5 (Lcica, Germany), Individual images were acquired with oil-immersion objective (x40) using Leica LAS AF software. The number of positively labeled cells was counted on single images generated from series of multiple Z-sections.
Statistical analysis
Data were analyzed using the Fisher exact test, X 2 test, 2.faetor ANOVA test, and multiple regression analysis to examine quantitative traits. When multiple comparisons were analyzed, theANOVAtest with a post-hoc Bonferroni adjustment was applied to minimize chance associations. Statistical significant was set at p < 0.05.
The statistical analysis of FOXP3 was performed using the Wilcoxon test in R.
RESULTS
Study subjects
The clinical characteristics of the study subjects arc summarized in Table 1 . Age was almost homogeneous except for the difference observed between non-allergic and treated olive pollen allergic groups (p == 0.033). There were slightly more women in the olive pollen allergic groups and this difference was statistically significant compared with the non-allergic and with allergic but not to olive pollen groups.
There are significant differences in the profile of immunoglobulin levels among the groups ofstudy
The mean levels of specific IgE, IgG4 and IgA antibodies to O. europaea pollen extract and total IgE were measured in and outside the pollen season. Total IgE and specific IgA levels were similar in both periods. However, specific IgE and IgG4 antibody levels were increased outside pollen season in the two olive pollen allergic groups, being only statistically significant the differences in IgG41evels of untreated olive pollen allergic patients between the two periods (229.2±306 inside vs 503±496 outside, p < 0.05). As there were no essential differences, Fig. I shows only the results in pollen season.
As expected, we found differences between groups in terms of inflammatory (total and specific IgE, Fig. lA ) and non-inflammatory (regulatory) response (specific IgG4 and IgA, Fig. IB) . Non-aUergic subjects showed normal total IgE levels, non-detectable olive poUen-specific IgE levels and. low specific IgA and IgG4 values. Asymptomatic olive sensitized subjects had the highest total IgE levels, and low levels of specific IgE, IgA and IgG4. Allergic patients non-related to olive pollen showed high total IgE levels, non-detectable or very low levels of specific IgE, IgA, and IgG4 levels. Untreated and treated olive pollen allergic patients showed the highest specific antibody levels, being levels of specific IgG4 statistically significant higher in treated subjects.
TGF-fJ regulatory cytokine is decreased in olive pollen allergic patients only during pollen season
We analyzed serum levels of Th I (IFN-y), Th2 (IL-5, IL-4, IL-13 and IL-9), Treg (IL-I 0, TGF-P), IL-17 and TNF -a. cytokines during and outside the pollen season.
The most relevant finding was related with the levels of a regulatory cytokine, TGF-p ( Fig.  2A) . Interestingly, untreated olive pollen allergic patients showed the lowest levels (5167±606pglml) during pollen season being statistically significant compared with treated olive pollen allergic patients (l 0 I56±2476pglml). However, outside pollen season, untreated patients showed the highest levels (34033±9606 pg/ml) being statistically significant compared to non-allergic subjects (9051±3202pglml). Although there were no statistically significant differences for mean levels ofTh2 cytokines between the groups, we found that the untreated olive pollen allergic group showed the highest percentage of subjects with detectable IL-5 levels during pollen season (86.3%) which was statistically increased Compared with the non-allergic group (37.5%).
Fig, I. Mean levels of total serum IgE and specific antibodies against olive pollen allergens during pollen season (expressed as median). A) Inflammatory response and (B) non-Inflammatory response. Number ofasterisks indicates: lie
For the rest of the cytokines analyzed there were no statistically significant differences.
FOXP3 mRNA expression andfluorescent confocal analysis confirm the decrease of this regulatory molecule in olive pollen allergic patients during pollen season and the recovery in patients with IT
The low TGF-B levels found in untreated oliveallergic population during 'pollen season led us to study mRNA expression levels for FOXP3, the most specific Treg marker. This analysis was performed in the RNA extracted from the subjects' PBMC. Relative mRNA expression of different groups compared with the non-allergic group is summarized in Fig. 2B . The most relevant result was a statistically significant decrease (more than 8-fold) in relative expression of FOXP3 mRNA in the untreated olive pollen allergic group compared to the non-allergic group during the pollen season. Outside the pollen season FOXP3 mRNA expression was normalized. These results were consistent with those found for TGF-p.
Furthermore, in order to obtain qualitative results to reinforce these data, the presence of regulatory T cells was analyzed in PBMCs in three subjects from each group, using fluorescent confocal microscopy analysis. Fig. 3 is a representative example of CD4+CD25+FOXPY differential presence in unfixed-PBMCs from: non-allergic, untreated and treated olive pollen allergic subjects. Clear differences were detected in the presence of triple or double-immunofluorescence: the highest presence was observed in non-allergic controls, followed by treated subjects and finally, the lowest expression of FOXP3 and CD25 was found in untreated patients. FOXP3 mRNA expression was quantified by RT-PCR in the RNA extracted from these PBMCs analyzed by the confocal method, obtaining the same results as previously (data not shown).
Both approaches confirm the significant decrease of FOXP3 in untreated olive pollen allergic subjects and how this expression is at least partially recovered in patients under specific immunotherapy.
DISCUSSION
Several immunomodulatory mechanisms may interact in the different responses to allergens. Serum levels of antibodies may indicate whether a patient is allergic or not to a given allergen. In fact, it has been demonstrated that a "healthy" immune response to specific allergens is characterized by IgA and IgG4 antibodies and no detectable levels of specific IgE. Indeed, specific immunotherapy can increase specific IgG4 and IgA levels without changing specific IgE levels (6) .
We analyzed humoral and cellular responses to olive pollen in a population who had lived for at least the previous ten years in an area with an extremely high load of olive pollen. The particular characteristics of this area include a higher response threshold to olive pollen than to other common allergens, sensitization to different olive pollen allergens than those found in the areas with a lower antigenic load, and a more severe clinical pattern (15) (16) (17) (18) (19) (20) .
Therefore, we decided to analyze the humoral response during and outside the pollen season as has been carried out for other allergens (22) . As expected, we found differences between groups regarding inflammatory and non-inflammatory responses (Fig. I) . Our results did not show any alteration related to specific non-inflammatory antibody levels (IgG4 and IgA) in non-allergic subjects. But they did reveal an increase in levels of non-inflammatory antibodies, mainly IgG4, in patients under specific immunotherapy, although specific IgE antibody levels were not affected, as was previously described for birch pollen IT (23) . Overall analysis shows that non-allergic and allergic but not to olive pollen groups presented a very poor specific antibody response. Asymptomatic olive sensitized subjects showed low levels of specific antibodies, but higher than the non-allergic group, and also showed the highest levels of total 19B. One may speculate that non-specific IgE protects against allergy, by blocking high affinity IgE receptors and that is why no allergic symptoms appear in these subjects. Untreated or treated olive pollen allergic groups showed the highest specific antibody levels, but the specific IgE/IgG4 ratio in untreated was between 6 to 10 times higher than treated patients (in and outside pollen season, respectively) due to differences in IgG4 levels and not to changes in specific IgE antibody levels. These results nail down the relevance of balance between specific IgE vs IgG4 levels for allergic response.
Activation of T cells plays an essential role in allergic diseases. The balance between Th I, Th2, Treg, and Th 17 and the specific cytokines secreted could be one of the most relevant determinants for the type of response (I, 5) .
In this work, the soluble cytokines did not reflect a clear discriminatory pattern of response, however one of our most interesting findings was the statistically significant decrease of''I'Gf'-]! (regulatory cytokine) in untreated olive pollen allergic subjects during the pollen season. This result was consistent with a significant decrease in relative FOXP3 mRNA expression and with the lower number of regulatory T cells detected by confocal microscopy compared with non-allergic or treated olive pollen allergic groups. Interestingly, an increase in the levels of TGF-p was observed in serum of this same group (untreated olive pollen allergic subjects) outside pollen season, with FOXP3 mRNA expression similar to those found in the other groups in these subjects. Although we have not a clear explanation, the analysis of all these results may highlight the importance of the relationship between TGF-p and FOXP3 for a regulatory response and also the need of studying different exposure periods in order to clarify this point.
Some authors report that TG F-p 1 is required for the maintenance of FOXP3 levels in peripheral Treg cells (13) and describe their role as a signalling mediator that is necessary for maintaining the suppressor function in Treg cells.
FOXP3 is currently the most specific marker for Treg and has been extensively studied (8) (9) (10) . PCR studies have shown that FOXP3 mRNA expression is differentially regulated in the CD4 1 T cells of controls compared with asthmatic patients (24) and that FOXP3 protein expression decreases in patients with stable asthma (25) . These authors speculate that corticosteroids (used in the treatment of allergic asthma) could restore the number of Treg in patients with controlled asthma. In some ways, a similar situation could happen in our patients under specific immunotherapy, whose FOXP3 mRNA expression is similar to that of the non-allergic group, indicating that the action of regulatory mechanisms in allergic subjects is diminished and is restored with specific immunotherapy.
With the purpose of confirming these results, three samples from each group of the study were also analyzed by confocal microscopy. This analysis showed the differential presence of regulatory cells by groups, with low levels seen in the untreated olive pollen-allergic patients as compared to non-allergic and treated groups. Despite the low number of samples studied, these results clearly reinforce our previous finding.
Some recent reports describe a decrease in FOXP3 expression in asthmatic subjects (25) and in allergic patients after treatment analyzing tissue samples (26) (27) . To the best of our knowledge, this is one of the first articles showing the differential presence of regulatory cells in unfixed PBMCs by confocal microscopy, clearly demonstrating changes in the presence of CD25 and FOXP3 in non-allergic and treated 01 ive pollen allergic versus untreated subjects.
This study shows that untreated olive pollenallergic patients have a deficient immunoregulatory response during the pollen season (and not outside season), as shown by the high ratio of specific IgE/IgG4, the low levels of TGF-p in serum, the significant decrease in FOXP3 mRNA expression and by the lower presence of regulatory cells in the PBMCs of olive pollen-allergic patients during peak pollen exposure. This kind of response is reversed by specific immunotherapy. However, in contrast with these results, some reports describe an increase of FOXP3 'Treg cells in the nasal mucosa after nasal allergen challenge (28) and in the lung, after provocation (29), and others were not able to detect any improvement in the number and function ofTreg cells, or any suppression ofTh2-type cell function in patients with seasonal allergic rhinitis after specific immunotherapy (30) (31) . These differences could be explained by our specific allergy model, because as has been previously demonstrated (32) , these changes in regulatory activity depend on the allergen tyPe, allergen dose and atopy status of the patients. This is the first time that such a study was performed on a population exposed to extremely high amounts of olive pollen and sensitized to 0. europaea with a clinical diagnosis mainly of asthma. This study provides important data on the pathogenesis of sensitization and clinical symptoms of this population, and in addition describes a series of regulatory processes from which we could learn how to improve current immunotherapy and open new horizons for the management of specific treatments.
